ID24219A - Turunan dibenzotiazotiazepina kristalin dan penggunaannya sebagai zat antipsikotik - Google Patents

Turunan dibenzotiazotiazepina kristalin dan penggunaannya sebagai zat antipsikotik

Info

Publication number
ID24219A
ID24219A IDW20000029A ID20000029A ID24219A ID 24219 A ID24219 A ID 24219A ID W20000029 A IDW20000029 A ID W20000029A ID 20000029 A ID20000029 A ID 20000029A ID 24219 A ID24219 A ID 24219A
Authority
ID
Indonesia
Prior art keywords
füä1
ethylü
dibenzoäb
hydroxyethoxy
piperazinyl
Prior art date
Application number
IDW20000029A
Other languages
English (en)
Indonesian (id)
Inventor
Evan William Snape
Original Assignee
Zeneca Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zeneca Ltd filed Critical Zeneca Ltd
Publication of ID24219A publication Critical patent/ID24219A/id

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D281/00—Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D281/02—Seven-membered rings
    • C07D281/04—Seven-membered rings having the hetero atoms in positions 1 and 4
    • C07D281/08—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D281/12—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems condensed with two six-membered rings
    • C07D281/16—[b, f]-condensed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Psychiatry (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Glass Compositions (AREA)
  • Iron Core Of Rotating Electric Machines (AREA)
  • Liquid Crystal Substances (AREA)
IDW20000029A 1997-08-01 1998-07-28 Turunan dibenzotiazotiazepina kristalin dan penggunaannya sebagai zat antipsikotik ID24219A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9716161.6A GB9716161D0 (en) 1997-08-01 1997-08-01 Process

Publications (1)

Publication Number Publication Date
ID24219A true ID24219A (id) 2000-07-13

Family

ID=10816746

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW20000029A ID24219A (id) 1997-08-01 1998-07-28 Turunan dibenzotiazotiazepina kristalin dan penggunaannya sebagai zat antipsikotik

Country Status (32)

Country Link
US (2) US6372734B1 (ko)
EP (2) EP1000043B1 (ko)
JP (2) JP2001512109A (ko)
KR (1) KR20010022241A (ko)
CN (1) CN1125058C (ko)
AT (2) ATE444959T1 (ko)
AU (1) AU739255B2 (ko)
BG (1) BG64796B1 (ko)
BR (1) BR9811061A (ko)
CA (1) CA2295792C (ko)
CY (2) CY2200161T2 (ko)
CZ (1) CZ299225B6 (ko)
DE (4) DE69842104D1 (ko)
EE (1) EE04550B1 (ko)
ES (2) ES2296568T3 (ko)
GB (2) GB9716161D0 (ko)
HK (2) HK1029992A1 (ko)
HU (1) HU228620B1 (ko)
ID (1) ID24219A (ko)
IL (1) IL133618A (ko)
MY (1) MY120999A (ko)
NO (1) NO20000484L (ko)
NZ (1) NZ501914A (ko)
PL (1) PL338384A1 (ko)
PT (2) PT1589008E (ko)
RU (1) RU2224754C2 (ko)
SI (2) SI1000043T1 (ko)
SK (1) SK287145B6 (ko)
TR (1) TR200000848T2 (ko)
TW (1) TW533207B (ko)
WO (1) WO1999006381A1 (ko)
ZA (1) ZA986904B (ko)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030216376A1 (en) * 2002-03-20 2003-11-20 Revital Lifshitz-Liron Crystalline forms of quetiapine hemifumarate
US7071331B2 (en) 2003-02-22 2006-07-04 Teva Pharmaceutical Industries Ltd. Synthesis of quetiapine and pharmaceutically acceptable salts thereof
TR200503401T1 (tr) * 2003-03-03 2008-03-21 Hetero Drugs Limited Kuetiapin (Quetiapine) Fumarat'ın yeni polimorfları
US7053115B2 (en) * 2003-04-07 2006-05-30 Hetero Drugs Limited Crystalline form of dorzolamide hydrochloride
ES2223294B2 (es) 2003-08-08 2005-10-01 Vita Cientifica, S.L. Procedimiento de preparacion de un compuesto farmaceuticamente activo.
US20060081361A1 (en) * 2004-09-13 2006-04-20 Gabbey Lawrence W Oil cooler with integral filter
WO2006035293A1 (en) * 2004-09-27 2006-04-06 Ranbaxy Laboratories Limited Polymorphic forms of quetiapine hemifumarate
WO2006056772A2 (en) * 2004-11-23 2006-06-01 Pliva Hrvatska D.O.O. Salts of quetiapine
GB0425729D0 (en) * 2004-11-23 2004-12-22 Pliva Res & Dev Ltd Heterocyclic compounds
ES2234447B1 (es) * 2005-03-07 2006-03-01 Union Quimico-Farmaceutica S.A. Procedimiento para la obtencion de un derivado de 11-(4-sustituido-1-piperazinil)dibenzo(b,f)(1,4)tiazepina.
WO2006113425A1 (en) * 2005-04-14 2006-10-26 Teva Pharmaceutical Industries Ltd. Process for preparing quetiapine fumarate
US20070072840A1 (en) * 2005-05-30 2007-03-29 Pandya Bhargav Polymorphic forms of quetiapine
WO2007036599A1 (en) 2005-09-30 2007-04-05 Fermion Oy New crystallization process of quetiapine hemifumarate
EP1948628A1 (en) 2005-10-28 2008-07-30 Fermion Oy Quetiapine hemifumarate purification by crystallization
WO2007062337A2 (en) * 2005-11-18 2007-05-31 Astrazeneca Ab Crystalline forms
CN101360725B (zh) * 2005-11-18 2011-09-21 阿斯利康公司 固体制剂
US20090069292A1 (en) * 2005-11-18 2009-03-12 Astrazeneca Ab Liquid Formulations
US8389510B2 (en) * 2005-11-18 2013-03-05 Astrazeneca Ab Crystalline forms
CN101360724A (zh) * 2005-11-18 2009-02-04 阿斯利康公司 盐形式
CZ300451B6 (cs) * 2006-07-03 2009-05-20 Farmak, A. S. Zpusob prípravy solí 2-[2-(4-dibenzo[b,f][1,4]thiazepin-11-yl-1-piperazinyl)ethoxy]ethanolu (quetiapinu) a jejich cištení
WO2008066620A2 (en) * 2006-10-20 2008-06-05 Concert Pharmaceuticals Inc. Dibenzothiazepine derivatives
PT1958617E (pt) 2007-02-14 2010-10-28 Lesvi Laboratorios Sl Composições farmacêuticas contendo fumarato de quetiapina
EP2144892A2 (en) * 2007-03-29 2010-01-20 Teva Pharmaceutical Industries Ltd. Improved process for preparing quetiapine fumarate
US8101597B2 (en) * 2007-05-07 2012-01-24 Actavis Group Ptc Ehf Quetiapine salts and their polymorphs
US20090082334A1 (en) * 2007-09-25 2009-03-26 Protia, Llc Deuterium-enriched quetiapine
US8461145B2 (en) * 2007-12-05 2013-06-11 Janssen Pharmaceutica Nv Dibenzoazepine and dibenzooxazepine TRPA1 agonists
DE202009018024U1 (de) 2008-08-01 2010-12-09 Krka Tovarna Zdravil, D.D., Novo Mesto Quetiapin-Zusammensetzung
US20100069356A1 (en) * 2008-09-17 2010-03-18 Auspex Pharmaceuticals, Inc. Dibenzothiazepine modulators of dopamine, alpha adrenergic, and serotonin receptors
US20120071649A1 (en) 2009-03-04 2012-03-22 Ranbaxy Laboratories Limited Process for the preparation of quetiapine fumarate
DK2742152T3 (en) 2011-08-12 2017-07-31 Qiagen Gmbh PROCEDURE FOR ISOLATING NUCLEIC ACIDS

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE787249A (fr) 1971-08-05 1973-02-05 Squibb & Sons Inc Derives amino d'acides pyrazolopyridine carboxyliques, leurs esters et les sels de ces composes, ainsi que leurs procedes de preparation
GB8607684D0 (en) * 1986-03-27 1986-04-30 Ici America Inc Thiazepine compounds
GB8705574D0 (en) * 1987-03-10 1987-04-15 Ici Plc Preparation of thiazepine compound

Also Published As

Publication number Publication date
HU228620B1 (en) 2013-04-29
ES2296575T1 (es) 2008-05-01
DE69842104D1 (de) 2011-03-03
JP2009102345A (ja) 2009-05-14
CN1265101A (zh) 2000-08-30
HK1029992A1 (en) 2001-04-20
EP1000043A1 (en) 2000-05-17
SK287145B6 (sk) 2010-01-07
DE05011169T1 (de) 2008-11-06
JP2001512109A (ja) 2001-08-21
HUP0002663A3 (en) 2001-10-29
EE200000062A (et) 2000-10-16
HK1081962A1 (en) 2006-05-26
EP1589008B1 (en) 2011-01-19
ZA986904B (en) 1999-02-01
RU2224754C2 (ru) 2004-02-27
CY2200161T2 (el) 2010-07-28
TW533207B (en) 2003-05-21
PL338384A1 (en) 2000-10-23
CY2200162T2 (el) 2010-07-28
NO20000484D0 (no) 2000-01-31
ES2296575T3 (es) 2010-02-05
SI1000043T1 (sl) 2010-01-29
SK1302000A3 (en) 2000-06-12
CN1125058C (zh) 2003-10-22
CZ2000341A3 (cs) 2000-05-17
GB9716161D0 (en) 1997-10-08
BG64796B1 (bg) 2006-04-28
AU739255B2 (en) 2001-10-04
ATE496037T1 (de) 2011-02-15
GB9814882D0 (en) 1998-09-09
CA2295792C (en) 2007-04-17
SI1589008T1 (sl) 2011-04-29
NO20000484L (no) 2000-03-16
WO1999006381A1 (en) 1999-02-11
ATE444959T1 (de) 2009-10-15
TR200000848T2 (tr) 2000-08-21
PT1589008E (pt) 2011-03-23
PT1000043E (pt) 2009-11-30
MY120999A (en) 2005-12-30
ES2296568T3 (es) 2011-05-06
DE98936529T1 (de) 2008-11-20
AU8549898A (en) 1999-02-22
KR20010022241A (ko) 2001-03-15
EE04550B1 (et) 2005-10-17
CA2295792A1 (en) 1999-02-11
DE69841216D1 (de) 2009-11-19
IL133618A (en) 2004-02-08
IL133618A0 (en) 2001-04-30
ES2296568T1 (es) 2008-05-01
US6372734B1 (en) 2002-04-16
NZ501914A (en) 2001-09-28
US20020147186A1 (en) 2002-10-10
CZ299225B6 (cs) 2008-05-21
HUP0002663A2 (hu) 2001-09-28
EP1589008A1 (en) 2005-10-26
BR9811061A (pt) 2000-09-19
BG104176A (en) 2000-08-31
EP1000043B1 (en) 2009-10-07

Similar Documents

Publication Publication Date Title
ID24219A (id) Turunan dibenzotiazotiazepina kristalin dan penggunaannya sebagai zat antipsikotik
CO5200832A1 (es) Derivados de acidos heterociclicos, o una sal farmaceuticamente aceptable de los mismos, que son agentes antidiabeticos y antiobesidad
DE69718835D1 (de) Verfahren zur Herstellung von (N-Phenylacetyl-N-2,6-xylyl)methyl Alaninat
RU93005051A (ru) Способ получения катионных кристаллов гр или производных гр, катионные кристаллы человеческого гр или производных человеческого гр, фармацевтические препараты, использование процесса кристаллизации
DE69432158D1 (de) Verfahren zur Herstellung von optisch aktiven 2-Amino-1-phenylethanol Derivaten
BR0115121A (pt) Compostos n-((1,2,4)triazoloazinil)tiofenossulfonamida como herbicidas
DE69813053D1 (de) Verfahren zur Herstellung von optisch aktiven Azetidin-2-Carbonsäurederivaten
DE69321304D1 (de) Verfahren zur Herstellung von optisch aktivem 4-Methyl-2-oxetanon
DE60036758D1 (de) Verfahren zur Herstellung von optisch aktiver 3,3,3-Trifluor-2-hydroxy-2-methylpropionsäure und deren Salze
DE69410222D1 (de) Verfahren zur Herstellung von optisch aktiven Erythro-3-amino-1,2-epoxy-Verbindungen
FI971891A (fi) Säätölaite aluksen pääenergialähteen tuottaman energian optimaalisen käytön saavuttamiseksi
AU638829B2 (en) Composition for disinfecting water by the electrochlorination process and use of this composition
DE69200795D1 (de) Verfahren zur Herstellung von L-Prolinederivaten.
DE69500362D1 (de) Verfahren zur Herstellung 5,6-dihydroxyindol-Derivate ausgehend von Dopa
DE69127219D1 (de) Verfahren zur Herstellung von optisch aktiven Alkyl-3-aryl-3-hydroxypropionaten
DE68928788D1 (de) Verfahren zur Herstellung von optisch aktiven 3,4-Dihydroxybuttersäurederivaten
DE59812729D1 (de) Verfahren zur Herstellung von 1,3-Dioxanverbindungen
ITRM940832A0 (it) "cerotto per assorbimento transcutaneo a rilascio controllato di fitoassociazione"
SE9602418D0 (sv) Process for the preparation of organic salts of N'N-diacetylcystine
SE9602476D0 (sv) Process for the preparation of organic salts of N'N -diacetylcystine
ITRM940842A0 (it) "cerotto per assorbimento transcutaneo a rilascio controllato di fitoassociazione eventualmente arricchita"
ITRM940839A0 (it) "cerotto per assorbimento transcutaneo a rilascio controllato di fitoassociazione eventualmente arricchita"
ITRM940843A0 (it) "cerotto per assorbimento transcutaneo a rilascio controllato di fitoassociazione"
ITRM940830A0 (it) "cerotto per assorbimento transcutaneo a rilascio controllato di fitoassociazione"
RU97102180A (ru) Гомеопатическое лекарственное средство, обладающее спазмолитической активностью "спазминал-arn"